In Vitro Anti-tumor Activity of Azulene Amide Derivatives

In Vivo. 2018 May-Jun;32(3):479-486. doi: 10.21873/invivo.11264.

Abstract

Background/aim: There exist few research articles regarding the anticancer activity of azulene-related compounds. We investigated here the relative cytotoxicity of 10 azulene amide derivatives against cancer and normal cells.

Materials and methods: Cytotoxicity against four human oral squamous cell carcinoma (OSCC) cell lines and three human oral normal cells (gingival fibroblasts, periodontal ligament fibroblasts and pulp cells) was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-zolium bromide method. Antitumor activity was evaluated by tumor-specificity (TS) (ratio of mean 50% cytotoxic concentration (CC50) against normal cells to that against OSCC cell lines) and potency-selectivity expression (PSE) (ratio of TS to CC50 against tumor cells). Apoptosis-inducing activity was evaluated by cleavage of poly ADP-ribose polymerase and caspase-3 with western blot analysis.

Results: N-Propylguaiazulenecarboxamide [1] showed the highest TS and PSE values, compared to that of doxorubicin, and induced apoptosis in two OSCC cell lines. QSAR analysis demonstrated that their tumor-specificity of azulene amide derivatives was correlated with hydrophobicity and molecular shape.

Conclusion: Compound [1] can be considered as a lead compound for manufacturing new anticancer drug candidates.

Keywords: Azulene amides; apoptosis; cytotoxicity; hydrophobicity; molecular shape; tumor specificity.

MeSH terms

  • Amides / chemistry
  • Amides / pharmacology*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Azulenes* / chemistry
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Doxorubicin / pharmacology
  • Fibroblasts / drug effects
  • Humans
  • Molecular Structure

Substances

  • Amides
  • Antineoplastic Agents
  • Azulenes
  • Doxorubicin